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Abstract
Background: The need for cost-effective neurorehabilitation is driving investment into technologies for patient
assessment and treatment. Translation of these technologies into clinical practice is limited by a paucity of evidence
for cost-effectiveness. Methodological issues, including lack of agreement on assessment methods, limit the value
of meta-analyses of trials. In this paper we report the consensus reached on assessment protocols and outcome
measures for evaluation of the upper extremity in neurorehabilitation using technology. The outcomes of this
research will be part of the development of European guidelines.
Methods: A rigorous, systematic and comprehensive modified Delphi study incorporated questions and statements
generation, design and piloting of consensus questionnaire and five consensus experts groups consisting of
clinicians, clinical researchers, non-clinical researchers, and engineers, all with working experience of neurological
assessments or technologies. For data analysis, two major groups were created: i) clinicians (e.g., practicing therapists
and medical doctors) and ii) researchers (clinical and non-clinical researchers (e.g. movement scientists, technology
developers and engineers).
Results: Fifteen questions or statements were identified during an initial ideas generation round, following which the
questionnaire was designed and piloted. Subsequently, questions and statements went through five consensus rounds
over 20 months in four European countries. Two hundred eight participants: 60 clinicians (29 %), 35 clinical
researchers (17 %), 77 non-clinical researchers (37 %) and 35 engineers (17 %) contributed. At each round
questions and statements were added and others removed. Consensus (≥69 %) was obtained for 22 statements on i)
the perceived importance of recommendations; ii) the purpose of measurement; iii) use of a minimum set of measures;
iv) minimum number, timing and duration of assessments; v) use of technology-generated assessments and
the restriction of clinical assessments to validated outcome measures except in certain circumstances for
research.
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Conclusions: Consensus was reached by a large international multidisciplinary expert panel on measures
and protocols for assessment of the upper limb in research and clinical practice. Our results will inform the
development of best practice for upper extremity assessment using technologies, and the formulation of
evidence-based guidelines for the evaluation of upper extremity neurorehabilitation.
Keywords: Neurology, Assessment, Upper extremity, Rehabilitation technology, Robotics, Evaluation,
Outcome measures
Background
Assessment has been defined as a “detailed process
which aims to define the nature and impact of an im-
pairment and devise a treatment plan” [1]. Technologies
are being developed for use in the assessment and treat-
ment of patients with neurological conditions in both
clinical and research environments [2, 3]. Development,
funded by governments, research, and commercial orga-
nizations, is driven by the need for evidence-based
neurological rehabilitation. But translation of new tech-
nologies into clinical practice is limited by a lack of
evidence for effectiveness.
Methodological issues, including small sample sizes,
lack of consensus on standardized assessment protocols
and outcome measures, currently limit the value of
meta-analyses of trials for rehabilitation of the upper ex-
tremity [4]. There is therefore an urgent need for agreed
guidelines on measurement tools and assessment proto-
cols. Furthermore, new technology-based measurement
tools have the potential to be used alongside clinical
measures of impairment, activity and participation, but
need to be rigorously tested for usability, validity, reli-
ability, and responsiveness. Agreement is needed on
what parameters should be measured, using what tools
(both clinical scales and technologies) and protocols for
application; which assessments should be used in re-
search and clinical practice, and when these assessments
should be conducted.
The primary driver for this work was to improve ef-
fectiveness of upper extremity neurorehabilitation.
Damage to the central nervous system such as stroke,
multiple sclerosis (MS) or spinal cord injury (SCI) has
an impact on arm function. It is estimated that only
41 % of people with moderate to severe stroke and 71 %
with mild stroke regain dexterity [5] which is known to
affect performance in activities of daily living (ADL) [6, 7].
Reduced hand dexterity and associated limitations in ADL
as well as social activities have been identified as highly
prevalent in mid and late stages of MS [8–10]. “Improving
upper extremity recovery and function after stroke” [11],
“identification of effective treatments to slow, stop or re-
verse the accumulation of disability associated with MS”
[12] and “regaining arm/hand function after cervical SCI”
[13] are main priorities identified by patients and carers.
Wider effects are seen across society; in 2009 stroke alone
was estimated to cost the EU economy over €38 billion
with 50 % direct health care costs, 22 % productivity losses
and 29 % to the informal care of people with stroke [14].
In 2005 the total annual cost of MS in Europe was esti-
mated at €12.5 billion [15]. No European data was found
for SCI, however in Australia, economic costs per patient
were found to be higher for SCI than MS [16].
A positive relationship has been established between
intensity and duration of therapy and outcomes [17]; a
recent review suggested that strong evidence exists for
physical therapy interventions favoring intensive highly
repetitive task oriented and task-specific training in all
phases post-stroke [18]. Governments, research and
commercial organisations are investing in the develop-
ment of rehabilitation technologies, cognisant that they
are well placed to deliver this extra intensity, and have
the potential to deliver cost-effective rehabilitation.
However, translation of these technologies is limited by
a lack of evidence for effectiveness and optimum deliv-
ery intensity, timing and duration. In addition to this,
there is a need to identify which systems work best and
for whom, which is only possible when clinical trial evi-
dence with different systems and with patients having
different impairment levels can be compared.
There are currently no standardised international
evidence-based guidelines for either evaluation of upper
extremity rehabilitation, or for technology-supported
rehabilitation. Many published studies do not include
adequate activity level or patient-reported outcome mea-
sures, which impede comparisons. A failure to measure
these may have affected how the technologies were re-
ported. Standardised assessment guidelines are needed
to improve clinical practice, through better monitoring
of patient progress and evaluation of treatment tech-
niques. Agreed measures and protocols for assessment
will enable data comparison across research trials, facili-
tating meta-analyses and lead to more robust evidence
and consequently inform the design and development of
new rehabilitation technologies.
Usefulness of consensus methods has been demon-
strated in the development of clinical guidelines that
define essential elements of the quality of healthcare
[19–24]. Delphi methodology has been used to establish
Hughes et al. Journal of NeuroEngineering and Rehabilitation  (2016) 13:86 Page 2 of 14
consensus in the absence of unanimity of opinion due to
lack of scientific evidence or where the evidence is
contradictory [25–35]. Features of the Delphi method
include: anonymity (questionnaires are used to prevent
dominant individuals exerting undue influence), iteration
(processes occur in rounds to enable contributors to
change their minds in response to the views of their
peers), controlled feedback (showing the distribution of
the group’s response), statistical group response (ex-
pressing judgment using summary measures of the full
group response, giving more information than a single
consensus statement) [25, 31, 35–37].
The traditional Delphi uses a series of sequential ques-
tionnaires with controlled feedback [37]. A modified
Delphi consensus method has been applied in a variety
of ways [23, 24, 38] e.g., using an iterative process with
qualitative open-ended questioning in all rounds [39] or
using a checklist to which participants respond instead
of a first round questionnaire [40]. There is no empirical
evidence to guide the identification of the specific con-
tent of evidence-based guidelines for assessment. In such
cases consensus studies with experts have been advo-
cated as the “next best” option [34].
Aim
The aim of this research was to achieve European-wide
consensus on the evaluation of the upper extremity in
neurorehabilitation using technology. The consensus will
recommend a framework for assessment, including,
where possible, specific measures and how and when
they should be used in clinical practice and research.
The paper describes the modified Delphi methodology
and presents the outcome of this rigorous iterative
process through which consensus was reached among a
panel of international multidisciplinary experts. The out-
comes of this research will be combined with other data




Monitoring and advisory groups were initially formed.
The purpose of the monitoring group was to oversee the
Delphi technique, to define the rules of engagement, the
process of data collection, and the criteria for consensus
(these will be explained in more detail in subsequent
sections). Monitoring members were either experts in
using rehabilitation technologies for assessment and
treatment and members of the European Cooperation in
Science and Technology (EU COST) Action TD1006
(2011–2015) European Network on Robotics for Neu-
roRehabilitation, or experts in the Delphi methodology.
The purpose of the advisory group was to participate in
the ideas generation rounds, and to contribute in the
design and piloting of the questionnaire. Advisory mem-
bers were professionals with expertise in using technolo-
gies for assessment and management of neurological
conditions and members of the above mentioned EU
COST Action TD1006.
Meeting convenors (volunteers from the EU COST
Action TD1006 membership) contacted their profes-
sional networks and invited those interested who met
the inclusion criteria to join the consensus expert
groups. The inclusion criteria were: self-reported experi-
ence in neurological assessments or technologies,
employed in European institutions, and different profes-
sional backgrounds to allow the creation of two major
groups: i) practicing clinicians who treat patients as the
focus of their daily work (e.g., therapists, medical doc-
tors, etc.) and ii) researchers (clinical researchers, non-
clinical researchers e.g. movement scientists, technology
developers and engineers). The experts were all self-
selected based on their interest in the subject area.
Delphi procedure
A Modified Delphi consensus exercise was implemented
in three stages. The monitoring group decided that fewer
rounds were necessary for Stages 1 and 2 as these were
preparation stages for the consensus exercise in Stage 3.
Stage 1- Ideas generation (three rounds): This aimed
to identify principal factors with regard to assessment,
for example, defining the purpose of assessment, the sort
of and timing of technological and traditional outcome
measures. The domains considered included impair-
ments at the body and body part level, person level
activity limitations, and societal level restrictions of
participation [41].
Stage 2 - Design and piloting of consensus question-
naire (two rounds): This aimed to: generate further
questions based on the minutes of previous meetings;
describe the Delphi methodology to the team and to
pilot initial questions/statements. The following rules
were adopted to build the questionnaire. Multiple choice
questions/statements were used to try and identify which
specific measures should be used. A statement would
include what would be measured; the choices would
include the specific measures to choose from. Partici-
pants would then choose the measures they deemed
appropriate to measure the specific construct. When
there was lack of consensus following discussion
questions were reworded for clarification or changed
to generic “Yes or No” questions based on the discus-
sion that had taken place. Piloting was also used to
refine the definition of consensus prior to the consen-
sus rounds [25, 42, 43] and to ensure rigour in the
design of first-round questions [44] and the choice of
measurement methods and their analysis in subse-
quent rounds [25, 45].
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Stage 3- Consensus (five rounds): This aimed to iden-
tify which statements consensus could be gained on. To
do this, background information on the guidelines,
Delphi methodology and the rules of engagement were
explained to the participants; specifically, that the Delphi
method was chosen in order to reach a consensus on
outcome measure recommendations using a 3-stage data
collection process. Participation was irrespective of
whether the experts had taken part in the previous
round.
Data collection and voting
The feasibility of using an anonymous audience response
system (ARS; TurningPoint Technologies, Youngstown,
OH, USA) to enable polling using a PowerPoint 2010
presentation and electronic voting devices (zappers) was
established in stage 2. Voting was undertaken in stage 3.
Where no consensus was reached there was a subse-
quent discussion and a second round of voting which
either achieved consensus, or generated new questions,
or informed amendments to existing questions to facili-
tate the gaining of consensus in the next round. Mem-
bers of the monitoring committee were responsible for
instigating discussions on a statement by statement basis
and recording comments expressed by the experts
during those discussions using a tablet. There was a
maximum time limit of 15 min on the discussion time
of any individual statement. The moderator was the
Project Investigator of the EU Cost Action Group.
Consensus procedure
The reported level of agreement which constitutes con-
sensus varies [25, 34], but is generally recommended to
be set at an agreed threshold of 70 % or above prior to
commencing the study, with the potential to change
with subsequent rounds [25, 46]. A threshold of 75 % or
higher of participants voting on a particular answer was
set for Round 1. Agreement reaching the threshold
would result in the statements being excluded from sub-
sequent rounds and included in the guidelines. Where
agreement on statements did not reach this threshold,
the statements would be amended as mentioned above.
This procedure of re-evaluation continued until either
the consensus rate was achieved or until the Delphi
panel members no longer modified their previous re-
sponses (or comments). In those cases when both the
level of agreement and the type of comments on the re-
entered questions no longer changed it was agreed that
a further round would not achieve consensus. The com-
ments and suggested additions were collated and
reviewed for consistency and overlap by the monitoring
group. Inconsistent or overlapping additions were omit-
ted; the others were developed for consideration in the
following consensus round.
In analysing the data, and in understanding the diffi-
culty of reaching consensus in the latter rounds where
iteration had featured, a pragmatic decision was taken
by the monitoring group to lower the threshold margin-
ally to 69 % (total participant response). This met pub-
lished criteria that consensus is achieved when 66.6 % of
a Delphi panel agrees [47].
Analysis of responses
Two groups comprising clinicians and researchers (clin-
ical and non-clinical researchers e.g. movement scien-
tists, technology developers, and engineers) were
considered for analysis, to inform the two proposed
guidelines – one for clinicians and one for researchers.
The percentage of participants who voted for each pos-
sible answer was calculated for all questions in all five
rounds.
Results
The monitoring group consisted of two clinical re-
searchers (JHB, AMH) and one Delphi expert (SBB).
The advisory group consisted of 13 professionals: three
clinicians and ten researchers (six clinical researchers,
three non-clinical researchers, one engineer). The com-
position of the expert groups is shown in Table 1.
Delphi procedure outcomes
Stage 1 - Ideas generation
Three preliminary meetings took place: the first with 13
contributors from 8 European countries, the second with
41 EU COST Action Group members from 22 countries,
and the third with nine contributors from six countries
(Table 1). Initial discussions focused on potential useful-
ness of guidelines, and identification of a suitable meth-
odology to establish them. The definition and purpose of
assessment, outcome measures currently used and those
that have the potential to be used were discussed
(Table 2) and consolidated into a format suitable for a
questionnaire.
Stage 2 – Design and piloting of the consensus
questionnaire
The feasibility of using the TurningPoint software and
electronic voting devices (zappers) as a method of
achieving consensus was established by the monitoring
and advisory group piloting initial statements/questions
(n = 15). Issues with the format of several questions in-
cluding the possibility for response bias, multiple ques-
tions, or lack of specificity were identified and the
questionnaire was revised. This was again piloted, dis-
cussed and refined. On the basis of discussion, new
topics were included, questions were reformatted to
allow for separate guidelines for research and clinical
areas. This process developed the statements (n = 34) for
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Round 1 of the consensus exercise. The piloting flow
chart (Fig. 1) shows how many questions were removed,
amended to facilitate understanding or added at each
stage.
C&R indicate whether the question/statement is ap-
plicable to practice in clinic (C) or to research (R).
Stage 3 – Consensus
For the statements in which no consensus was achieved,
on the basis of discussion, new topics were included,
and questions were reformatted. The consensus flow
chart (Fig. 2) shows how many questions were removed,
amended to facilitate understanding or added at each
stage.
C&R indicate whether the question/statement is
applicable to practice in clinic (C) or to research (R).
In total 65 statements were considered. For ease of
viewing, the statements relating to clinicians and re-
searchers, have been combined resulting in 22 consensus
statements (Table 3) and 20 statements where consensus
was not achieved (Table 4).
Consensus statements outcomes
Key areas of consensus were established for both clini-
cians and researchers (Table 3). The expert population
surveyed agreed that the publication of recommenda-
tions on an assessment framework and outcome mea-
sures for use in technology based neurorehabilitation
would be useful. An agreed definition of the purpose of
measurement was established. Clinicians and researchers
agreed that a minimum defined set of measures (both
currently available and those with future potential)
should be used.
Agreement was reached on standardising patient
assessments to a minimum of four face-to-face
assessments for a treatment programme: baseline (be-
ginning of the programme), interim (during the
programme), final (end of the programme), and
follow-up (a set period of time after the end of the
programme), which should take place separately from
treatment and last no longer than three hours was
thought to be clinically important as well as
achievable.
The expert population agreed that technology-
generated data (e.g. kinematic, kinetic and activity
measures) should be used whilst non-technology based
Table 1 Composition of monitoring, advisory and consensus expert groups





Clinical researchersb Non-clinical researchersc Engineersd
Ideas generation rounds
Brussels 25/11/2011 13 3 6 3 1
Southampton 19/03/2012 41 3 12 0 26
Brussels 28/04/2012 9 1 5 1 2
Design and piloting of the questionnaire meetings
Brussels 07/11/2012 8 1 6 0 1
Brussels 08/11/2012 12 3 6 3 0
Delphi rounds
Madrid(Round 1) 13/11/2012 34 3 3 26 2
Bucharest (Round 2) 26/03/2013 35 26 3 6 0
Enschede (Round 3) 08/04/2013 71 12 14 27 18
Pisa (Round 4) 10/05/2013 43 15 11 11 6
San Sebastian (Round 5) 05/06/2013 25 4 5 7 9
Total for Delphi rounds 208 60 35 77 35
aPractising clinicians defined as those who treat patients as the focus of their daily work (e.g., therapists, medical doctors, etc.)
bClinical researchers defined as clinicians whose focus is on research
cNon-clinical researchers defined as researchers with no healthcare qualification (e.g. movement scientists)
dEngineers defined as technology developers or engineers
Table 2 Ideas Generation Rounds – Discussion topics
Usefulness of guidelines in technology-based neuro-rehabilitation
What is the aim in generating and publishing the guidelines and
how these will be used?
What is the purpose of measurement?
Should recommendations be based on the ICF Framework and
include measures in each category?
Should preference be given to measures that span more than one
ICF category?
Are the following measures are useful for clinicians and researchers?
If so, which measures/information/variables?
Technology-generated data EMG, cortical or eye movement,
measures of impairment, activity, participation measures
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measures should be restricted to validated outcome
measures except in certain circumstances for research
(for example if they were validating a new outcome
measure). Other measures which were recommended to
be included were self-report and personalized goal-
oriented measures.
Specific agreement was reached for measures to be
used by researchers including quality of movement,
EMG, neurophysiological measures and neuropsycho-
logical and other non-motor domain measures including
attention, neglect, engagement, reaction times and pain).
Specific agreement reached for measures to be used by
clinicians included patient effort and non-technology
measures of activity.
There was agreement to include existing clinical
outcome measures in clinical practice (e.g. the
Action Research Arm Test) but experts did not
agree on the need to limit research studies to these
outcome measures only. Statements that were
excluded (Table 4) were frequently those in which
specific outcome measures or times for assessment
were suggested.
Discussion
Technologies can provide valid, reliable and sensitive as-
sessment tools that, when used alongside clinical mea-
sures, can inform clinical decision-making and provide
richer data on patient outcomes. There is now a clear
need for guidelines for clinicians and researchers to
optimise technology-based assessment and application
of clinical measures and procedures. This paper
reported the consensus of a panel of experts and the
process through which it was reached. It will inform
clinical and research evidence-based guidelines for
evaluation of technology-based upper extremity
neurological rehabilitation.
Using the modified Delphi technique, we gained
consensus from 208 European participants across multi-
disciplinary professional expert groups including both
practicing clinicians and researchers. In general, clini-
cians and researchers agreed that: i) recommendations
on assessments for use in technology-based neuro-
rehabilitation would be useful; ii) the purpose of meas-
urement is to design therapy and to measure progress;
iii) a minimum defined set of measures should be used;
Fig. 1 Flowchart of the design and piloting of the questionnaire
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Fig. 2 Flowchart of the Consensus Rounds
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Table 3 Consensus statements









1 Q1. Recommendations on an assessment framework and outcome
measures for use in technology based neuro-rehabilitation are useful.
79 (27) 100 (3) 77 (24)
2 Q3. The purpose of measurement is to design therapy (initial decisions
and changes in therapy programme) and to measure progress.
86 (30) 81 (21) 100 (9)
2 Q6. Technology-generated data (from a device, wearable and
environmental sensors, wii, social networking, etc.) should be used
by both clinicians and researchers.
83 (29) 81 (21) 89 (8)
3 Q2.1.
Q2.2
Recommendations including a minimum defined set of measures
should be used by:
Clinicians 83 (59) 100 (12) 80 (47)
Researchers 87 (62) 100 (12) 85 (50)
3 Q28. Measures that are not currently widely used or practical, but which
have the potential to be useful should be included.
92 (65) 92 (11) 92 (54)
3 Q18R. Performance quality measures (Co-ordination, smoothness of
movement, precision/accuracy of movement, number of errors
and successes - during the performance of a task), Response to
perturbations (disturbances during movement), and Compensatory
(abnormal) movements should be used by researchers.
73 (55) 64 (7)a 75 (48)
3 Q7C.
Q7R.
A range of kinematic measures (active ROM at a single joint, extent
of workspace at multiple joints, speed of movement, etc.) should be
used by:
Clinicians 76 (54) 75 (9) 76 (45)
Researchers. 83 (59) 75 (9) 85 (50)
3 Q17C.
Q17R.
A range of kinetic measures (e.g., Isometric force in a range of
muscles and positions, Isokinetic force in a range of muscles and
movements, endurance, Grip strength, Non-neural muscle stiffness
(resistance to passive movement), and Spasticity) should be used by:
Clinicians 53 (40)a 79 (11) 47 (29)a
Researchers. 55 (56)a 77 (10) 52 (46)a
3 Q19R. A range of EMG measures (e.g., Co-contraction, Synergies, Muscle
onset time, and Inappropriate muscle activity, etc.) should be used
by researchers.
83 (59) 91 (10) 82 (49)
3 Q20C. Effort during movement measure (amount of assistance required to
complete task) should be used by clinicians.
73 (48) 67 (8) a 74 (40)
3 Q21R. A range of neuropsychological and other non-motor domain measures
(e.g., Attention +/− when distracted, Neglect, Engagement, Reaction
time, and Pain associated with movement, etc.) should be used by
researchers.
100 N/Ab 100 (59)
3 Q23C.
Q23R.
Non-technology based measures of Impairment should be restricted
to validated outcome measures (e.g. Fugl Meyer (FM), Grip or muscle
strength), except in certain circumstances (e.g., experimental research,
development of new technologies or for the purposes of validation)
for use of:
Clinicians 76 (54) 75 (9) 76 (45)
Researchers 71 (44) 80 (8) 69 (36)
3 Q14C.
Q14R.
Technology-based measures of Activity (e.g., Measures that can be
used at home, Body-worn sensors to monitor activity, and Body-worn
sensors as surrogate measures of function (e.g., the WMFT)) should be
used by:
Clinicians 53 (31)a 50 (6)a 54 (25)a
Researchers 72 (39) 70 (7) 73 (32)
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iv) the minimum number of, timing and duration of
assessments should be defined; v) technology-generated
assessments should be used by both clinicians and
researchers in conjunction with clinical assessments
which should be restricted to validated outcome
measures (except in certain circumstances for research).
Self-reported and personalized goal-oriented measures
were also recommended to be added in the guidelines.
Excluded statements were frequently those in which
specific outcome measures or times for assessment were
suggested. In discussion surrounding these points, the
consensus expert groups suggested this may be a reflec-
tion on the practicalities of what can be achieved given
the resource issues affecting most health services. Also,
whilst it might have been expected that clinical assess-
ments should take less time than quantitative research
assessments, the discussion included the issue that nerve
conduction tests might be performed within clinical
assessments. This work has delivered the largest “expert
consensus” view within the field with good multidiscip-
linary representation, which we consider will be critical
to future adoption of the guidelines by clinicians and
researchers.
The modified Delphi technique has recently been used
successfully in the development of a tool to assess qual-
ity of stroke care across European populations [48], to
identify a set of clinically useful outcome measures for
assessment of adults receiving treatment for spasticity [49]
and to develop a post-stroke checklist to standardize
follow-up care for stroke survivors [50]. The modified
Delphi technique used in the current research was found
to be a flexible and adaptable tool to gather and analyse
relevant data from the European cross-disciplinary
groups.
The statements with the highest overall agreement
were on the usefulness of the guidelines, recommenda-
tions about the duration and timing of assessments and
the recognition that given the speed of technology
change, the guidelines should be written to allow inclu-
sion of future potentially useful measures. The need for
assessments is emphasised within many healthcare pro-
fessional training programmes, however there is scant
Table 3 Consensus statements (Continued)
3 Q13C. Non-technology based measures of Activity should be restricted to
validated outcome measures such as the Action Research Arm Test
(ARAT) or Wolf Motor Function Test (WMFT) for use of clinicians.
72 (51) 67 (8) a 73 (43)
3 Q15R. In research, non-technology based Measures of Participation measures
should be restricted to validated outcome measures such as the
Stroke Impact Scale (SIS), Short Form-36 (SF36), except in certain
circumstances (e.g., experimental research, development of new
technologies or for the purposes of validation).
85 (45) 71 (5) 87 (40)
3 Q15C. In clinic, non-technology based Measures of Participation measures
should be restricted to validated outcome measures such as the
Stroke Impact Scale (SIS), Short Form-36 (SF36).
70 (50) 75 (7) 70 (41)
3 Q24R. A range of Neurophysiology Measures (e.g., EEG, TMS/MEP, and
functional neuro-imaging) should be used by researchers.
76 (47) 100 (9) 72 (38)
4 Q32. Self-reported measures (e.g. Motor Activity Log) should be used. 91 (39) 93 (14) 89 (25)
4 Q34. Personalized, goal orientated measures (e.g. COPM) should be used. 84 (37) 81 (13) 86 (24)
5 Q37R.
Q37C.
Four face-to-face patient assessments should be collected for a
treatment programme: Baseline (beginning of the programme),
interim (during the programme), final (end of the programme), and
follow-up (a set period of time after the end of the programme),
other than data collected automatically by technology for:
Clinicians 100 (24) 75 (3) 100 (21)
Researchers 83 (20) 75 (3) 81 (17)
5 Q39R.
Q39C.
Assessment should take place separately from treatment by:
Clinicians 96 (23) 100 (4) 90 (19)
Researchers. 83 (20) 75 (3) 81 (17)
5 Q40R.
Q40C.
Maximum time for assessment is 3 h for:
Clinic 92 (22) 75 (3) 90 (19)
Research 83 (20) 75 (3) 81 (17)
C&R indicate whether the question/statement is applicable to practice in clinic (C) or to research (R)
a: The monitoring group agreed that the statement should be accepted as having reached consensus for the following reasons: These was clear agreement from
practicing clinicians, and the majority of non-clinicians and non-practicing clinicians also voted for this option or the majority of experts voted for this option (the
remaining votes were spread in support of the different individual measures which are encompassed by this statement)
b: Practicing clinicians did not vote
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detail on how to choose and implement such assess-
ments in international clinical guidelines, which is
perhaps why this was viewed as such an important
subject on which to reach consensus.
Agreement was reached on standardising patient
assessments to a minimum of four face-to-face assess-
ments for a treatment programme at: baseline (beginning
of the programme), interim (during the programme), final
(end of the programme), and follow-up (a set period of
time after the end of the programme). It was agreed that
these assessments should take place separately from treat-
ment and last no longer than three hours which was
thought to be clinically important as well as achievable. It
is recognised that variation exists in what is supported in
clinical practice in European healthcare systems. In some
countries, costs for the inclusion of an assessment phase
during clinical practice follow-up are not supported. In
others, even though active rehabilitation has ended, people
still have check-ups with their rehabilitation physician for
monitoring purposes, at least for the first year after stroke.
In clinical practice, practical issues (such as transfers of
patients to home, other wards or hospitals) may reduce
the number of post baseline assessments from occurring.
However, these assessments are essential for tailoring
treatments and increasingly to financially justify therapy
by providing evidence for the cost benefit of a
Table 4 Statements for which consensus was not achieved
Round Question number Statements Average agreement
for all options overall %
1 Q4. Recommendations (including technology-based and clinical measures)




Which categories – kinematic, kinetic, quality of movement, effort, and
neuropsychological and other non-motor domain measures are most





The amount of time researchers and clinicians would be willing to spend












The amount of time researchers and clinicians would be willing to spend
on using outcome measures for evaluation of patient progress.
14 (R)
14 (C)
3 Q18C. Which Quality of Movement Measures should be recommended for clinicians
to use.
20
3 Q19C. Which Muscle Activity Measures (EMG) should be recommended for clinicians
to use.
17
3 Q20R. Which Effort During Movement Measures should be recommended for
researchers to use.
20
3 Q21C. Which Neuropsychological and other non-motor domain measures should be
recommended for clinicians to use.
14
3 Q29. Which non-technology-based Measures of Impairment should be recommended. 20
3 Q13R. In research, non-technology-based Measures of Activity should be restricted to
validated outcome measures such as the Action Research Arm Test (ARAT) or
Wolf Motor Function Test (WMFT).
20
3 Q30. Which non-technology-based Measures of Activity should be recommended. 17
3 Q31. Which non-technology-based Measures of Participation should be recommended. 25
3 Q22R.
Q22C.
Which categories of technology-based Measures of Participation should be
recommended for researchers and clinicians to use.
20 (R)
20 (C)
3 Q24C. Which Neurophysiology Measures should be recommended for clinicians to use. 20
4 Q33. Which Self-Reported Measures should be recommended. 33
4 Q36R.
Q36C.
The minimum frequency of face-to-face patient assessment (other than data





The amount of time researchers and clinicians are to spend in face-to-face





The amount of time researchers and clinicians are to spend in spend in
face-to-face assessment of patients’ progress.
20 (R)
20 (C)
C&R indicate whether the question/statement is applicable to practice in clinic (C) or to research (R)
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rehabilitation programme. With increasingly stretched
resources there is likely to be greater emphasis on being
able to demonstrate value for money in the future.
The only formalised practice guidelines on stroke re-
habilitation to explicitly address specific assessments,
within the authors’ knowledge, are the Dutch Stroke
Guidelines which are issued by the Royal Dutch Society
of Physical Therapy [51]. The Dutch Stroke Guidelines
state a minimal and supplemental set of clinical outcome
measures along with recommendations for when these
should be recorded (in the week of admission and of dis-
charge, before multidisciplinary meetings and at the end
of the 1st week, 3rd month and 6th month post-stroke).
The Dutch Guidelines also state that if patients are con-
tinuing treatment during the chronic phase, monthly
evaluations are advised. Adoption of the guidelines
should ensure that whatever the practical issues, the
same assessments measures are used.
Many meta-analyses and systematic reviews of re-
search trials have commented on the lack of consistency
of outcome measures, and highlighted that it would be
useful if outcome measures of arm function and mea-
sures of repetitions during training could be used in
future studies to gain a better understanding of the
effects of training [4, 52]. Within this Delphi study, con-
sensus was lacking for statements in which we tried to
select specific measures to recommend. This may reflect
either the impracticality of using specific measures, a
desire to not be restricted to using specific measures,
differing education or practices throughout Europe, a
lack of awareness of the current research evidence or
just different opinions. The work of this study is comple-
mented by a recent Italian national Delphi consensus on
specific outcome measures to be used specifically for
evaluating robot assisted rehabilitation after stroke. It
identified eight clinical scales for evaluation of the upper
limb and ten clinical scales for evaluation of the lower
limb [53]. The paper indicates that differing educational
and/or practicing cultures among multiple countries
may be an important issue. Additionally, this may point
to difficulty experienced among experts to specify a
restricted set of outcome measures for a rather broad
field of application, covering the full range of neuro-
rehabilitation (addressing multiple disorders, involving a
variety of conventional techniques as well as emerging
technology-assisted methods).
The high consensus for the inclusion of measures not
currently widely used or practical, but which have the
potential to be useful, pending technological innovation,
reflects a recognition by researchers and clinicians that
current assessment tools are inadequate and that there
is a need for change. Technology can generate high
quantities of data. It is difficult to know what data will
provide therapists with the most useful information for
treatment planning for patients. Movement duration
and smoothness for example have been found to be
associated with real clinical improvement in upper
limb function [54]. Technology-based measures now
need to be incorporated into easy to use clinical and
home-based rehabilitation systems to facilitate the
continuity of objective assessments allowing better
longer term self-management. This study provides a
mandate for this.
Strengths and limitations
A multidisciplinary panel of clinicians, non-practicing
clinicians and non-clinicians from over 23 countries
have contributed to consensus on assessments and as-
sessment protocols. The rigorous modified Delphi tech-
nique enabled questions and statement to be honed and
simplified and potential misinterpretations to be identi-
fied and revised. The initial aim, as previously stated,
was to achieve a consensus recommending a framework
for assessment, including, where possible, specific mea-
sures and how and when they should be used in clinical
practice and research. To try and achieve this, initially
questions and statements were very detailed and were in
some cases ambiguous, which led to a lack of consensus.
The process ensured that these questions and statements
were adapted to become unambiguous and more gen-
eric, providing practical guidance without compromising
professional autonomy.
A comparable Delphi survey [55] reported potential
linguistic misinterpretation of questions and state-
ments by a multi-lingual panel as a limitation. We
mitigated for this potential risk by using an advisory
group representing each profession and comprising
eight nationalities and six different first languages,
but all fluent English speakers, to develop and agree
upon the initial statements and questions. Throughout
the consensus process we were also careful to explain
each question and statement and ask participants if
they understood before proceeding. However, given
the multidisciplinary, multi-lingual membership of the
expert groups, the potential for misinterpretation
remained. It is also noted that use of a different form
of data collection (e.g. a written questionnaire admin-
istered by e-mail) may have produced different
results.
Impact on future research and clinical practice
Our results will be combined with information on
current published guidelines and a systematic review of
the literature [56], to form European evidence-based
clinical and research guidelines for the evaluation of
technology-based upper extremity neurorehabilitation.
The guidelines, an output from the EU COST Action
TD1006 (2011–2015) European Network on Robotics
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for NeuroRehabilitation, will have an impact on upper
limb neurorehabilitation research by promoting well-
informed and agreed standards for selection of measure-
ment tools and protocols for assessment. If adopted they
will underpin comprehensive data comparison across re-
search trials, facilitating meta-analyses which will conse-
quently improve evidence. The results of this consensus
study will also inform clinical practice, allowing for im-
proved assessments, better-informed clinical decision
making, and thus choice of intervention and systematic
monitoring of patient progress and evaluation of individ-
ual treatment techniques and potentially better patient
outcomes (Additional file 1).
Conclusion
The modified Delphi technique was found to be a
flexible and adaptable tool to gather and analyse data
from a large international multidisciplinary expert panel
on measures and protocols for assessment of the upper
limb in research and clinical practice. The main consen-
sus points included:
 Recognition of the need for guidelines on the
evaluation of the upper extremity
neurorehabilitation using technology
 Standardising patient assessments to a minimum
of four face-to-face assessments for a treatment
programme: baseline (beginning of the programme),
interim (during the programme), final (end of the
programme), and follow-up (a set period of time
after the end of the programme). These assessments
should take place separately from treatment and last
no longer than three hours
 Clinical assessments should be restricted to
validated outcome measures
 Technology-generated assessments should be used
in conjunction with clinical assessments
 Self-reported and personalized goal-oriented
measures should also be included
 Measures which have the potential to be useful in
the future due to technological progression should
be included. Researchers and clinicians recognise
that current assessment tools are inadequate to
assess in detail the full spectrum of upper limb
function, and that there is a need for change as
new technologies become more widely available.
Addressing these will positively impact both research
and clinical practice. Our results will inform the devel-
opment of best practice for upper extremity assessment
using technologies, and the formulation of evidence-
based guidelines for the evaluation of upper extremity
neurorehabilitation.
Additional file
Additional file 1: Data from Delphi rounds. (XLSX 246 kb)
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